Abstract
Objective
To retrospectively evaluate enhanced recovery after surgery (ERAS) protocol administration,
hospital length of stay, 30-day readmission, and complication rates among cystectomy
and/or urinary diversion patients with benign or malignant indication.
Materials and methods
Data was extracted retrospectively for cystectomy and/or urinary diversion performed
at our institution from June 2016 to May 2019. Descriptive statistics, Chi squared,
Wilcoxon rank-sum, binary logistic regression, and linear regression functions in
R 4.0.4 (R Foundation), R Package “Tidverse” V1.3.0.9, and RStudio V1.44.1106 (RStudio,
PBC) were used to analyze data.
Results
102 patients met selection criteria with 36 and 66 patients in the benign and malignant
indication cohorts, respectively. Significant differences between cohorts included
BMI, age, opioid exposure, and spinal anomalies. The malignant cohort had higher ERAS
completion rates for preoperative and intraoperative protocols (41% and 53% vs 14%
and 19%). The mean ERAS item administration for benign and malignant indication patients
differed significantly (2.9 vs 4.2, P < 0.01). Logistic regression demonstrated benign indication was significantly associated
with ERAS failure (OR 4.25, 95% CI 1.18 – 21.03, P = 0.043). Higher ERAS item administration sum was associated with shorter hospitalizations
and lower complication rates (P = < 0.01, P = 0.019). No association was observed for 30-day readmission.
Conclusion
The benign urinary diversion/cystectomy population more frequently possesses characteristics
adverse to ERAS protocol completion and in our study received fewer ERAS protocol
items. This was associated with longer hospitalizations and higher postoperative complication
rates. Population-specific ERAS protocols targeted at increasing ERAS completion could
reduce morbidity.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to UrologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The enhanced recovery after surgery (ERAS) pathway for patients undergoing major elective open colorectal surgery: a meta-analysis of randomized controlled trials.Clin Nutr. 2010; 29 (Epub 2010 Jan 29. PMID: 20116145): 434-440https://doi.org/10.1016/j.clnu.2010.01.004
- Enhanced Recovery After Surgery Study Group. Adherence to the enhanced recovery after surgery protocol and outcomes after colorectal cancer surgery.Arch Surg. 2011; 146 (Epub 2011 Jan 17. PMID: 21242424): 571-577https://doi.org/10.1001/archsurg.2010.309
- Enhanced Recovery After Surgery (ERAS) program attenuates stress and accelerates recovery in patients after radical resection for colorectal cancer: a prospective randomized controlled trial.World J Surg. 2012;; 36 (PMID: 22102090): 407-414https://doi.org/10.1007/s00268-011-1348-4
- Enhanced recovery protocol after radical cystectomy for bladder cancer.J Urol. 2014; 192 (Epub 2014 Feb 8. PubMed PMID: 24518775): 50-55https://doi.org/10.1016/j.juro.2014.01.097
- Enhanced Recovery Pathways Vs Standard Care After Cystectomy: A Meta-analysis of the Effect on Perioperative Outcomes.Eur Urol. 2016; 70 (Epub 2016 Jun 11. Review. PubMed PMID: 27297680; PubMed Central PMCID: PMC5149115): 995-1003https://doi.org/10.1016/j.eururo.2016.05.031
- Cystectomy for benign disease: readmission, morbidity, and complications.Can J Urol. 2018; 25 (PubMed PMID: 30281004): 9473-9479
- Understanding Simple Cystectomy for Benign Disease: A Unique Patient Cohort With Significant Risks.Urology. 2017; 110 (10.1016/j.urology.2017.07.002. Epub 2017 Aug 26. PubMed PMID: 28847690): 239-243
- Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS(®)) society recommendations.Clin Nutr. 2013; 32 (Epub 2013 Oct 17. PMID: 24189391): 879-887https://doi.org/10.1016/j.clnu.2013.09.014
- Adherence to the Enhanced Recovery After Surgery Protocol and Outcomes After Colorectal Cancer Surgery.Arch Surg. 2011; 146: 571-577https://doi.org/10.1001/archsurg.2010.309
- Enhanced recovery program in colorectal surgery: a meta-analysis of randomized controlled trials.World J Surg. 2014; 38 (PMID: 24368573): 1531-1541https://doi.org/10.1007/s00268-013-2416-8
- Rationale for and approach to preoperative opioid weaning: a preoperative optimization protocol.Perioper Med (Lond). 2017; 6 (PMID: 29201359; PMCID: PMC5700757): 19https://doi.org/10.1186/s13741-017-0079-y
- Opioid-induced hyperalgesia: a qualitative systematic review.Anesthesiology. 2006; 104 (PMID: 16508405): 570-587https://doi.org/10.1097/00000542-200603000-00025
- Predictors of outcome after anterior cervical discectomy and fusion: a multivariate analysis.Spine (Phila Pa 1976). 2009; 34 (PMID: 19139666): 161-166https://doi.org/10.1097/BRS.0b013e31819286ea
Article Info
Publication History
Published online: August 30, 2021
Accepted:
August 19,
2021
Received:
December 5,
2020
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
